What is the latest BI stock price?
The latest stored price for BI is Rs 107.62 as of 2026-09-18.
gimli
BI stock AI analysis
BI Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
BILCARE LTD. is a small-cap stock in Healthcare. This Gimli page shows the latest available BI price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹107.62
1W return
+19.80%
1M return
+6.16%
3M return
+90.48%
6M return
n/a
1Y return
n/a
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
n/a
ROCE
n/a
RSI
69.31
Turnover
₹0.81 cr
Why it can matter in screens
- Momentum: BI is above 50DMA, below 200DMA; RSI is 69.31.
- Returns: 1D +5.00%, 1W +19.80%, 1M +6.16%, 3M +90.48%, 1Y n/a.
- Trend levels: 52W high ₹111.51, 52W low ₹55.00, off high -3.49%.
- Liquidity: latest turnover is ₹0.81 cr; volume vs 20D is +1.28%.
- Valuation/profitability: PE n/a, PB n/a, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR -58.00%, 3Y profit CAGR n/a.
Quick Answers
Is BI above its 50DMA and 200DMA?
BI is above 50DMA, below 200DMA. The latest 50DMA is 77.60 and the latest 200DMA is n/a.
What are BI PE, ROE and ROCE?
BI has PE n/a, ROE n/a, and ROCE n/a in Gimli's latest available snapshot.
How has BI performed recently?
BI has returned +6.16% over 1 month, +90.48% over 3 months, and n/a over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 5.02 cr | -4.16 cr | -6.35 cr | -2.70 |
| 2025-12-31 | 7.27 cr | 3.80 cr | 2.71 cr | 1.15 |
| 2025-09-30 | 5.30 cr | 2.09 cr | 1.04 cr | 0.44 |
| 2025-06-30 | 186.36 cr | 17.15 cr | -3.73 cr | n/a |
| 2025-03-31 | 194.03 cr | 28.84 cr | 17.58 cr | n/a |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-03-31 | 32.96 cr | 12.17 cr | 4.00 cr | 1.70 |
| 2024-03-31 | 26.18 cr | 10.34 cr | 5.34 cr | 2.27 |
| 2023-03-31 | 17.71 cr | 507.89 cr | 390.79 cr | 165.97 |
| 2022-03-31 | 445.29 cr | 79.29 cr | -17.78 cr | -7.55 |
Balance sheet
No recent data available.
Cash flow
No recent data available.
Shareholding Trend
No recent data available.
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 440,829.82 cr | 36.388220 | +15.50% | +11.45% |
| DIVISLAB | DIVI S LABORATORIES LTD | 248,876.81 cr | 85.407280 | +18.37% | +53.39% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 163,807.57 cr | 75.106636 | +17.33% | +35.67% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 128,608.22 cr | 65.670049 | +21.03% | +13.94% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 116,723.14 cr | 26.011308 | +16.04% | +10.70% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 33.401961 | +10.25% | -11.64% |
| LAURUSLABS | LAURUS LABS LIMITED | 105,487.98 cr | 96.587446 | +21.77% | +111.64% |
| MAXHEALTH | MAX HEALTHCARE INS LTD | 102,122.47 cr | 70.799892 | +14.33% | -10.58% |
Try these prompts
- Analyze BILCARE. with valuation, momentum and industry peers
- Compare BI with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare BI with other Healthcare stocks
Data snapshot: 2026-09-18. Not investment advice.